In the Pharmacovigilance and Technovigilance unit, we identify, collect, evaluate, and prevent reports of adverse events and incidents that occur during the use of our products, in order to ensure the integrity of our patients and continuously monitor the risk-benefit profile of our products.
The World Health Organization (WHO) defines it as the science and activities related to the detection, assessment, understanding, and prevention of adverse events or any other health problem related to medicines or vaccines.
The World Health Organization (WHO) defines it as a post-market surveillance system for medical devices (MD) that identifies, collects, evaluates, manages, and disseminates adverse events or incidents that occur during the use of medical devices (MD), in order to improve the protection of health and patient safety.
Any undesirable clinical situation that occurs in a patient who has been administered a pharmaceutical product and that does not necessarily have a causal relationship with such use; in this case, the key point is the coincidence in time, without any suspicion of a causal relationship.
Any undesirable event that causes harm to the patient, user, operator, or others, or that poses a risk of harm, which may or may not be causally associated with one or more medical devices.
To report an adverse event or incident related to any of our products, please contact us through:
Emails:
Phone numbers of our subsidiaries: